6 recruiting, 5 completed, 2 unknown, 1 enrolling by invitation. 4 Phase 2, 2 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 1, Recruiting 1, Suspended 1, Terminated 1 |
| Not applicable | 2 | Enrolling by invitation 1, Recruiting 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Communicable Diseases, Emerging: new trials by email Literature Review of Communicable Diseases, Emerging trials Research Report on Communicable Diseases, Emerging
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BRAVO is a Phased Outbreak-response Study in the DRC Evaluating ERVEBO® Vaccination in ~20,000 Frontline Workers During the 2026 BDV Outbreak, Step A Assesses Real-world Effectiveness, Safety, and Impact on Severe Disease and Mortality, While Generating Evidence for Future BDV Vaccination Strategies ERVEBO Vaccination - Ebola, Bundibugyo Virus Disease (BVD) | Phase 4 | Recruiting | Epicentre | 20000 | 2026-09-19 | 2026-10-29 |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases Multi-Agent Integrated Smart Toolkit for Emerging Infectious Diseases, Routine Practices - Emerging Infectious Diseases, COVID-19 | Not applicable | Enrolling by invitation | Peking University | 108 | 2026-08-10 | 2026-08-19 |
| Biological Collection on Emerging Infectious Diseases and Their Treatments Emerging Infectious Diseases and Their Treatments | Not yet recruiting | University Hospital, Toulouse | 5300 | 2026-06-15 | 2026-06-29 | |
| Post-Emergency Optimization of Antibiotic Therapy for Urinary Tract Infection (UTI) Adaptation of antibiotics therapy for outpatient urinary infection following emergency care - Urinary Tract Infections, Antiobiotic Stewardship | Recruiting | Centre Hospitalier Intercommunal Creteil | 330 | 2026-06-01 | 2026-08-26 | |
| ARN-75039 Lassa Fever Treatment in West Africa ARN-75039 high, Intravenous ribavirin, ARN-75039 low - Lassa Fever | Phase 2 | Suspended | Arisan Therapeutics, Inc. | 135 | 2026-02-14 | 2026-07-06 |
| Development of a Rapid Diagnostic Test to Identify Crimean-Congo Hemorrhagic Fever - Research and Development Testing Infectious Diseases, Emerging | Completed | Liverpool School of Tropical Medicine | 196 | 2025-06-17 | 2026-08-27 | |
| ISTH/ANRS 0409s INTEGRATE Lassa Fever Study Favipiravir, Ribavirin, Dexamethasone - Lassa Fever | Phase 2 / Phase 3 | Recruiting | Irrua Specialist Teaching Hospital | 1755 | 2025-05-02 | 2026-02-04 |
| RVF and Other Emerging Infectious Diseases in East and Central Africa Evidence of past or recent RVF exposure - Rift Valley Fever, Hemorrhagic Fevers, Viral | Recruiting | Washington State University | 5000 | 2025-02-01 | 2026-10-05 | |
| Rapid Molecular Diagnosis and Detection of Emerging Infectious Diseases in Patients With Tropical Fever (Tropifever) Diagnosis algorithm according to the delay between travel and consultation - Infectious Diseases in Febrile Patients Returning From Tropical Countries | Not applicable | Recruiting | Assistance Publique - Hôpitaux de Paris | 564 | 2024-08-26 | 2025-06-06 |
| Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions Emerging Infectious Diseases, Communicable Diseases | Recruiting | Assistance Publique - Hôpitaux de Paris | 800 | 2024-06-03 | 2026-02-17 | |
| Collaborative Open Research Initiative Study (CORIS-1) No intervention. This is an observational study - Patient Engagement, COVID-19 | Unknown | Chisquares Incorporated | 15000 | 2024-06-01 | 2024-04-10 | |
| Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III Ebola Virus Disease | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 203 | 2022-08-25 | 2025-07-18 | |
| EU SolidAct: An Adaptive Pandemic and Emerging Infection Platform Trial Baricitinib, Placebo - COVID-19, Emerging Infectious Disease | Phase 2 / Phase 3 | Terminated | Oslo University Hospital | 290 | 2021-06-03 | 2023-02-06 |
| Epidemiology and Clinical Characteristics of Emerging and Re-emerging Infectious Diseases With Epidemic Potential in Mali Observational Study - Febrile Illness | Unknown | University Clinical Research Center, Mali | 400 | 2020-06-18 | 2022-07-01 | |
| Acceptability of Telehealth Triage Using Robotic Systems in COVID-19 Doctor Spot - COVID-19, Telemedicine | Completed | Brigham and Women's Hospital | 40 | 2020-03-10 | 2022-09-21 | |
| Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases Plasma - Communicable Diseases, Communicable Diseases, Emerging | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2015-03-04 | 2025-05-16 | |
| Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza Anti-Influenza Immune Plasma, Standard Care - Influenza A, Influenza B | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 98 | 2010-12-01 | 2017-09-05 |
COVID-19 (4) · Hemorrhagic Fevers, Viral (4) · Communicable Diseases (3) · Hemorrhagic Fever, Ebola (2) · Lassa Fever (2) · Burnout, Professional (1) · Chikungunya Fever (1) · Dengue (1) · Emergencies (1) · Infections (1) · Influenza in Birds (1) · Influenza, Human (1) · Mpox, Monkeypox (1) · Neglected Diseases (1)
Disease Attributes (17) · Pathologic Processes (17) · Pathological Conditions, Signs and Symptoms (17) · Infections (16) · Communicable Diseases (14) · RNA Virus Infections (10) · Virus Diseases (10) · Coronaviridae Infections (4) · Coronavirus Infections (4) · Lung Diseases (4) · Nidovirales Infections (4) · Pneumonia (4) · Pneumonia, Viral (4) · Respiratory Tract Diseases (4) · Respiratory Tract Infections (4)
Standard of Care (2) · Dexamethasone (1) · Immunoglobulin M (1) · Observation (1) · Ribavirin (1) · baricitinib (1) · favipiravir (1)
National Institute of Allergy and Infectious Diseases (NIAID) (3) · Assistance Publique - Hôpitaux de Paris (2) · Arisan Therapeutics, Inc. (1) · Brigham and Women's Hospital (1) · Centre Hospitalier Intercommunal Creteil (1) · Chisquares Incorporated (1) · Epicentre (1) · Irrua Specialist Teaching Hospital (1) · Liverpool School of Tropical Medicine (1) · Oslo University Hospital (1) · Peking University (1) · University Clinical Research Center, Mali (1) · University Hospital, Toulouse (1) · Washington State University (1)
France (5) · United States (4) · Democratic Republic of the Congo (2) · Liberia (2) · Nigeria (2) · Turkey (Türkiye) (2) · Austria (1) · Belgium (1) · China (1) · Czechia (1) · Germany (1) · Greece (1) · Hungary (1) · Ireland (1) · Italy (1)
Ana Cubas Isabel Atienzar, PhD (1) · Bridgette J Billioux, M.D. (1) · Domique Costagliola, PhD (1) · John Beigel, MD (1) · Jose R Arribas, MD PhD (1) · Jue Liu, Doctor (1) · Ken McCormack, PhD (1) · M. Kariuki Njenga, PhD (1) · Richard Davey, MD (1) · Richard T Davey, M.D. (1)
PMID 28522352, PMID 33662134, PMID 34473343, PMID 35571871, PMID 36627655, PMID 41652539
U01AI151799 (1)